MARKHAM, ON, Sept. 20, 2017 /CNW/ - MedReleaf Corp. (TSX:
LEAF) ("MedReleaf" or the "Company"), Canada's first and only ISO 9001 and ICH-GMP
certified cannabis producer, today announced that it has been added
to the North American Marijuana Index (the "Index") as part of its
quarterly rebalancing, and by extension, included in the Horizon
Medical Marijuana Life Sciences ETF (TSX: HMMJ) ("HMMJ").
"MedReleaf's addition to the North American Marijuana Index is a
recognition of our position as one of the industry's largest and
most respected cannabis producers. We have achieved this position
through our relentless focus on serving our patients and we will
continue to focus on driving growth and profitability in our
business to create long-term shareholder value," said Neil Closner, CEO of MedReleaf. "Our inclusion
in Horizon's Medical Marijuana Life Sciences ETF provides another
avenue for investors to participate in our growth."
The HMMJ is the world's first exchange-traded fund to offer
direct exposure to the performance of a basket of North American
publicly listed companies with significant business activities in
the cannabis industry. The HMMJ seeks to replicate, to the extent
possible, the performance of the Index, net of expenses. It is
important to note that that HMMJ may not hold all of the
constituent names in the Index. Constituents of the Index are
listed on North America's public
equity markets with business activities that include
biopharmaceuticals, medical manufacturing, distribution,
bioproducts and other ancillary businesses to the cannabis
industry. To be eligible for inclusion a stock must meet minimum
asset and liquidity thresholds, and no single stock may exceed 10%
of the weight of the Index when rebalanced.
About MedReleaf Corp.
MedReleaf sets The Medical Grade Standardâ„¢ for cannabis in
Canada and around the world.
The first and only ICH-GMP and ISO 9001 certified cannabis producer
in North America, MedReleaf is a
R&D-driven company dedicated to patient care, scientific
innovation, research and advancing the understanding of the
therapeutic benefits of cannabis. Sourced from around the
world and perfected in one of two state of the art facilities in
Ontario, MedReleaf delivers a
variety of premium products to patients seeking safe, consistent
and effective medical cannabis.
For more information on MedReleaf, its products, research and
how the Company is helping patients #livefree, please visit
MedReleaf.com or follow @medreleaf.
SOURCE MedReleaf Corp.